At the same time, Rb protein is inactivated in a high percentage of NSCLC through the inactivation of the p16INK4 gene, which results in elevated cyclin dependent kinase activity, as described in a later section. The gene discussed is CDKN2A; the disease is non-small cell lung carcinoma.